Ascites in peripartum cardiomyopathy: case report

Authors

  • I. Made Bayu Surya Dana Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali, Indonesia
  • Lisa Anggriani Susanto Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali, Indonesia
  • Ketut Suryana Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.18203/2349-3933.ijam20210284

Keywords:

Ascites, Peripartum cardiomyopathy, Furosemide, Spironolactone, Abdominal paracentesis

Abstract

Ascites is the abnormal accumulation of excess fluid in peritoneal cavity.1 Normally, peritoneal cavity contains 25–50 mL of ascitic fluid, which allows for the movement of bowel loops past one other and helps hydrate serousal surfaces. Cirrhosis is the most common cause of ascites in the Western world (75%), followed by peritoneal malignancy (12%), heart failure (5%) (include peripartum cardiomyopathy), and peritoneal tuberculosis (2%). A 19-years-old woman diagnosed with peripartum cardiomyopathy. She came with chest pain and increased of her abdominal perimeter since 6 month ago, a month after she got cesarean delivery. She was given high protein and low sodium diet, water restriction, treated with furosemide 40 mg, spironolactone 25 mg, and abdominal paracentesis with total 1500 cc of yellowish ascites fluid was evacuated. Early detection is required in this case to ensure effective management without any complications. Treatment depends upon the cause of the ascites. Dietary sodium restriction and diuretics remains the first line therapy for its management. The use of diuretics needs close monitoring and follow up, including weight loss, electrolytes, and patient’s condition daily.

References

Amer MO, Elsiesy H. Ascites: Causes, Diagnosis, and Treatment. Liver Cirrhosis - Update and Current Challenges. 2017;6:117-137.

Garbuzenko DV, Arefyev NO. Current Approaches to The Management of Patients with Cirrhotic Ascites. World Journal of Gastroenterology. 2019;25(28):3738-752.

Tsao GG. Ascites. Sherlock’s Diseases Of The Liver And Biliary System. 2018;9:127-150.

Sliwa K, Anthony J. Late maternal deaths: a neglected responsibility. Lancet. 2016;387:2072-073.

Bauersachs J, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure. 2019.

Azibani F, Sliwa K. Peripartum Cardiomyopathy: an Update. Current Heart Failure Reports. 2018;15:297-306.

Sudarman BM, et al. Peripartum Cardiomyopathy (PPCM) : A Case Report and Review of Literatures. Indonesian Journal of Medicine and Health. 2018;9(11):60-67

Davis MB, Arany Z, McManara DM, Goland S, Elkayam U. Peripartum Cardiomyopathy. Journal Of The American College Of Cardiology. 2020;75:2.

Fortea JI, et.al. Cardiac Hepatopathy. Acute Liver Dysfunction - Principles and Practice. 2019.

Xu X, et al. Chinese guidelines on the management of ascites and its related complications in cirrhosis. Hepatology International. 2019;13:1-21.

McGibbon A, et.al. An Evidence-Based Manual for Abdominal Paracentesis. Digestive Diseases and Sciences. 2007;52:3307-315.

Downloads

Published

2021-01-27

Issue

Section

Case Reports